Landfar Bio-medicine Co., Ltd (SHE:000504)
8.62
-0.04 (-0.46%)
Feb 13, 2026, 3:04 PM CST
Landfar Bio-medicine Market Cap
Landfar Bio-medicine has a market cap or net worth of 2.84 billion as of February 13, 2026. Its market cap has decreased by -4.01% in one year.
Market Cap
2.84B
Enterprise Value
2.83B
Revenue
125.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.62
Market Cap Chart
Since October 24, 2002, Landfar Bio-medicine's market cap has decreased from 2.85B to 2.84B, a decrease of -0.31%. That is a compound annual growth rate of -0.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 2.84B | -3.69% |
| Dec 31, 2025 | 2.95B | 7.19% |
| Dec 31, 2024 | 2.76B | -23.75% |
| Dec 29, 2023 | 3.61B | -0.34% |
| Dec 30, 2022 | 3.63B | -37.42% |
| Dec 31, 2021 | 5.80B | 51.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guangdong VTR Bio-Tech | 3.25B |
| Cabio Biotech (Wuhan) | 3.23B |
| Shanghai Hile Bio-Technology | 3.19B |
| Suzhou Fushilai Pharmaceutical | 3.09B |
| Novoprotein Scientific | 3.05B |
| Shanghai Universal Biotech | 2.86B |
| Shandong Sito Bio-technology | 2.82B |
| Shanghai Serum Bio-Technology | 2.82B |